Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX-4975-05 Intra-articular Injection in Subjects With Chronic, Moderate-to-Severe Osteoarthritis Knee Pain

Trial Profile

An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX-4975-05 Intra-articular Injection in Subjects With Chronic, Moderate-to-Severe Osteoarthritis Knee Pain

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Capsaicin (Primary) ; Lidocaine
  • Indications Musculoskeletal pain
  • Focus Registrational; Therapeutic Use
  • Acronyms VICTORY-3
  • Sponsors Centrexion Therapeutics
  • Most Recent Events

    • 17 Sep 2019 According to a Centrexion Therapeutics media release, open-label topline results are expected in Q1 2020.
    • 04 Sep 2019 According to a Centrexion Therapeutics media release, data will be presented at at the 13th Annual PAINWeek National Conference taking place in Las Vegas, Nevada from September 3-7, 2019.
    • 28 Aug 2019 Planned End Date changed from 1 Dec 2019 to 1 Jan 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top